Board to announce bonus & dividend this week: Gujarat-based penny stock under Rs 5 accumulates agro commodity supply orders of Rs 297 crore, more than its market cap
The stock is trading at 1.10 times its book value and the stock is up by 126 per cent from its 52-week low of Rs 1.04 per share.
On Monday, shares of Murae Organisor Limited (Formerly known as Earum Pharmaceuticals Limited) hit a 5 per cent upper circuit to Rs 2.35 per share from its previous closing of Rs 2.24 per share. The stock’s 52-week high is Rs 2.73 per share and its 52-week low is Rs 1.04 per share. This penny stock under Rs 2 has been hitting consecutive 8 upper circuits.
Murae Organisor Ltd, an Ahmedabad-based company, is making significant strides in the agri-commodity sector, recently accumulating supply orders worth up to Rs 297 crore from various domestic institutional clients. These orders encompass essential agricultural commodities like mustard seeds, groundnuts, chickpeas, and other oilseeds and pulses, marking a substantial increase in the company's visibility and demand within India's institutional agri-supply market. This strategic move aims to achieve scale-based growth, improve operating leverage, and secure recurring commodity contracts, with the first tranche of orders valued at approximately Rs 57 crore slated for execution within the next 30 days.
The company's robust financial performance underpins its expansion. Murae Organisor reported a remarkable revenue from operations of Rs 854.82 crore in FY 2025, a multi-fold increase from Rs 2.54 crore in FY 2024. Net profit also surged to Rs 7.52 crore in FY 2025, compared to Rs 5.31 lakh in the previous fiscal year. In January 2025, the company successfully completed a Rs 46.47 crore Rights Issue to fund its ongoing expansion plans, further demonstrating its financial agility and commitment to growth.
In a bid to reward shareholders and fuel future growth, Murae Organisor's board of directors is scheduled to meet on June 13, 2025. The agenda includes considering and approving a bonus issue of equity shares and a dividend declaration of up to 100 per cent of the face value (Rs 2 per share) for FY 2024-25. Additionally, the company has set June 11, 2025, as the record date for a 1:2 stock split, wherein every equity share with a face value of Rs 2 will be sub-divided into two equity shares of Re 1 each, as approved by shareholders on May 29, 2025.
Looking ahead, Murae Organisor is strategically expanding into the agro-industrial sector with plans to acquire agricultural land in Kutch, Gujarat. This venture involves an estimated investment of Rs 20-25 crore to cultivate high-quality pomegranates and establish a state-of-the-art distillery facility. By tapping into this under-explored yet lucrative market segment, the company aims to diversify its product offerings, improve profit margins, and achieve sustainable long-term growth, leveraging government schemes that support agricultural and industrial development.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
About the Company
Murae Organisor Ltd, incorporated in 2012, operates within the pharmaceutical industry, focusing on the marketing, trading, and distribution of a diverse range of pharmaceutical formulations. The company markets over 120 products under its brand names, such as HYGNEX+, Erolon, and Calcybar, while outsourcing its manufacturing to third-party facilities. In addition to their branded products, Murae also trades in active pharmaceutical ingredients. Their product portfolio spans various therapeutic categories, including antibiotics, antimalarials, antihistamines, analgesics, dermatology products, neurological drugs, gastrointestinal drugs, and various supplements like calcium and multivitamins. Murae maintains an international presence, exporting to more than 15 countries across North America, CIS, Latin America, Africa, and Southeast Asia, with over 60 international products currently under registration.
According to Quarterly Results, the net sales increased by 59,845 per cent to Rs 515.53 crore and net profit increased by 144 per cent to Rs 2.85 crore in Q4FY25 compared to Q4FY24. In its annual results, the net sales increased by 33,554 per cent to Rs 854.82 crore and net profit increased by 14,940 per cent to Rs 7.52 crore in FY25 compared to FY24
The company has a market cap of Rs 281.43 crore and its 100 per cent stake is owned by public shareholders. The stock is trading at 1.10 times its book value and the stock is up by 126 per cent from its 52-week low of Rs 1.04 per share.
Disclaimer: The article is for informational purposes only and not investment advice.